Dr. Giorgio Bertolini studied chemistry at University of Milan with a thesis on stereoselective electrophilic amination and aldol condensation in the labs of Prof. Cesare Gennari. Then he moved to Polytechnic of Milan to complete his education at the Specialization School of Organic Synthetic Chemistry. He subsequently undertook postdoctoral research with Professor Barry M. Trost at Stanford University, where he worked on selective modification of steroids. In 1987, Giorgio joined the research laboratories of Zambon, where he started his industrial carrier as Medicinal Chemist in lead generation, hit identification, and optimization. After 12 years in medicinal chemistry, he became Process Chemistry Director of the Italian sites of the Clariant Life Science Molecules Business Unit. Following 20 years of experience in process chemistry in different companies, he is currently Senior Vice President Research & Development at Olon Group. Giorgio is now responsible for all the innovation activities of the group for both fermentative and chemical processes with particular focus on recombinant peptides, highly potent APIs, continuous processes, bioconversion, photo- and electrochemistry, and hazardous chemicals. Giorgio is currently vice-chair of the Innovation Committee of the European Fine Chemical Groups (EFCG) and member of the board of the Organic Chemistry Division of the Italian Chemical Society. He is the author or co-author of more than 70 patents and around 30 publications on major international Journals.